TRPV2 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, we recently showed that TRPV2 activation induced mitophagy associated with cell growth inhibition and stemness reduction in chronic myeloid leukemia (CML) cells (Maggi et al., 2022).